STOCK TITAN

AXT (NASDAQ: AXTI) 2025 revenue slips to $88.3M while net loss nearly doubles

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

AXT, Inc. reported weaker fourth quarter and full-year 2025 results, with ongoing investment in AI-related growth. Q4 2025 revenue was $23.0M versus $25.1M a year earlier, while full-year revenue declined to $88.3M from $99.4M. Net loss attributable to AXT widened to $3.5M in Q4 and $21.3M for 2025, compared with losses of $5.1M and $11.6M in 2024. On a non-GAAP basis, 2025 net loss was $18.0M. Despite losses, cash and cash equivalents rose sharply to $120.3M at December 31, 2025, supporting plans to double indium phosphide manufacturing capacity in 2026. Management expects sequential revenue growth in Q1 2026, driven mainly by indium phosphide demand for AI infrastructure, and continues to pursue a potential STAR Market IPO of its Tongmei subsidiary, which remains subject to regulatory review in China.

Positive

  • Cash position strengthened materially: Cash and cash equivalents increased to $120.3M at December 31, 2025, from $22.8M a year earlier, providing substantial liquidity to support capacity expansion and operations.
  • AI-driven growth focus: Management expects sequential revenue growth in Q1 2026, led by indium phosphide demand for AI infrastructure, and plans to double indium phosphide manufacturing capacity in 2026.

Negative

  • Revenue decline of more than 10%: Full-year 2025 revenue fell to $88.3M from $99.4M, reflecting softer conditions and export-permit challenges.
  • Losses widened significantly: GAAP net loss attributable to AXT, Inc. increased to $21.3M in 2025 from $11.6M in 2024, with non-GAAP net loss also nearly doubling.

Insights

AXT posts double-digit 2025 revenue decline but exits year with much stronger cash.

AXT generated full-year 2025 revenue of $88.3M, down from $99.4M, reflecting softer demand and export-permit headwinds. GAAP net loss attributable to AXT nearly doubled to $21.3M, indicating margin and scale pressures despite modest Q4 revenue of $23.0M.

Non-GAAP net loss for 2025 was $18.0M, highlighting the impact of $3.3M in stock-based compensation. At the same time, cash and cash equivalents climbed to $120.3M at December 31, 2025, giving the company flexibility to fund capacity expansion and navigate volatility.

Management plans to double indium phosphide capacity in 2026 and expects sequential revenue growth in Q1 2026 driven by AI infrastructure demand. The proposed STAR Market IPO of Tongmei remains subject to review by the CSRC and other Chinese authorities, so actual timing will depend on future regulatory approvals.

false 0001051627 0001051627 2026-02-19 2026-02-19
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ​

 ​
FORM 8-K
 ​
CURRENT REPORT
 ​
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 ​
Date of Report (Date of earliest event reported): February 19, 2026
 ​
AXT, INC.
(Exact name of registrant as specified in its charter)
 ​

 ​
Delaware
 
000-24085
 
94-3031310
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 ​

 ​
4281 Technology Drive
Fremont, California 94538
(Address of principal executive offices) (Zip Code)
 
Registrant’s telephone number, including area code: (510) 438-4700
 ​
Not Applicable
(Former name or former address, if changed since last report)
 ​
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 ​
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 ​
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 ​
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 ​
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 ​
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 ​
Emerging growth company
 ​
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 ​
Securities registered pursuant to Section 12(b) of the Act:
 ​
Title of each class:
 
Trading Symbol
 
Name of each exchange on which registered:
Common Stock, $0.001 par value
AXTI
The NASDAQ Stock Market LLC
 ​
 

 
Item 2.02 Results of Operations and Financial Condition
 ​
On February 19, 2026, AXT, Inc. issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2025.  A copy of the Company’s press release, announcing the results, is attached hereto as Exhibit 99.1 and incorporated herein by reference.
 
The information in Exhibit 99.1 hereto discussing the Company’s results of operations and financial condition for the quarter and fiscal year ended December 31, 2025, is being “furnished” in accordance with General Instruction B.2 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended.  The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference to such filing.
 ​
 ​
Item 9.01 Financial Statements and Exhibits
 ​
(d)       Exhibits
 ​
99.1     Press release dated February 19, 2026, regarding the financial results of AXT, Inc. for the quarter and fiscal year ended December 31, 2025.
 ​
 ​
EXHIBIT INDEX
 ​
Exhibit
Number
 
Description
     
99.1
Press release dated February 19, 2026, regarding the financial results of AXT, Inc. for the quarter and fiscal year ended December 31, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 ​ ​
 

 ​
SIGNATURES
 ​
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 ​
AXT, INC.
Date: February 19, 2026
By:
/s/ Gary L. Fischer
Gary L. Fischer
Chief Financial Officer and Corporate Secretary
 ​
 

Exhibit 99.1

 

 

axti-20250220xex99d1002.jpg
 

Exhibit 99.1

AXT, Inc. Fourth Quarter and Fiscal Year 2025 Results

February 19, 2026

Page 1 of 7

 ​

AXT, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

 ​

FREMONT, Calif., February 19, 2026 – AXT, Inc. (NasdaqGS: AXTI), a leading manufacturer of compound semiconductor wafer substrates, today reported financial results for the fourth quarter and fiscal year ended December 31, 2025.

 ​

Management Qualitative Comments

 

​“While we are disappointed that we didn’t receive as many export permits in Q4 as we had hoped, we are pleased to report that we have received some permits to date in 2026 and believe we are in a strong position to achieve sequential revenue growth in Q1, driven primarily by growth in indium phosphide for the AI infrastructure build-out,” said Morris Young, chief executive officer. “As we enter 2026 as a foundational supplier to this multi-year growth cycle, we are notably broadening our customer base to include Tier-1 companies to which we have previously had limited exposure. We are also on track to double our indium phosphide manufacturing capacity this year and have a strong balance sheet to support our continued business expansion."

 ​

Fourth Quarter 2025 Results

 ​

In order to provide better clarity on its operational and financial results, AXT reports its financial results on both a GAAP and non-GAAP basis. Non-GAAP results exclude stock-based compensation expense. Investors can find GAAP to non-GAAP reconciliation tables in the financial statements in this earnings release.  

 ​

 

Revenue for the fourth quarter of 2025 was $23.0 million, compared with $28.0 million for the third quarter of 2025 and $25.1 million for the fourth quarter of 2024.

 ​

 

GAAP gross margin was 20.9 percent of revenue for the fourth quarter of 2025, compared with 22.3 percent of revenue for the third quarter of 2025 and 17.6 percent for the fourth quarter of 2024.

 ​

 

Non- GAAP gross margin, after excluding charges for stock-based compensation, was 21.5 percent of revenue for the fourth quarter of 2025, compared with 22.4 percent of revenue for the third quarter of 2025 and 17.9 percent for the fourth quarter of 2024.

 ​

 

GAAP net loss, after minority interests, for the fourth quarter of 2025 was a net loss of $3.5 million, or $0.08 per share, compared with a net loss of $1.9 million, or $0.04 per share, for the third quarter of 2025 and a net loss of $5.1 million, or $0.12 per share, for the fourth quarter of 2024.

 ​

 

Non- GAAP net loss for the fourth quarter of 2025 was a net loss of $2.3 million, or $0.05 per share, compared with a net loss of $1.2 million, or $0.03 per share, for the third quarter of 2025 and a net loss of $4.3 million, or $0.10 per share, for the fourth quarter of 2024.

 ​

 

 

AXT, Inc. Fourth Quarter and Fiscal Year 2025 Results

February 19, 2026

Page 2 of 7

 

Fiscal Year 2025 Results (January 1 to December 31, 2025)

 ​

 

Revenue for fiscal year 2025 was $88.3 million, compared with $99.4 million in fiscal year 2024.  

 ​

 

GAAP gross margin for fiscal year 2025 was 12.7 percent of revenue, compared with 24.0 percent of revenue in fiscal year 2024.

 ​

 

Non- GAAP gross margin for fiscal year 2025 was 13.1 percent of revenue, compared with 24.3 percent of revenue in fiscal year 2024.

 ​

 

GAAP net loss for fiscal 2025 was a net loss of $21.3 million, or $0.49 per share, compared with a net loss of $11.6 million, or $0.27 per share for fiscal 2024.

 ​

 

Non- GAAP net loss for fiscal 2025 was a net loss of $18.0 million, or $0.41 per share, compared with net income of $8.5 million, or $0.20 per share for fiscal 2024.

 ​

STAR Market Listing Update

 ​

On January 10, 2022, AXT announced that Beijing Tongmei Xtal Technology Co., Ltd. (“Tongmei”), its subsidiary in Beijing, China, submitted to the Shanghai Stock Exchange (the “SSE”) its application to list its shares in an initial public offering (the “IPO”) on the SSE’s Sci-Tech innovAtion boaRd (the “STAR Market”) and the application was accepted for review. Subsequently, Tongmei responded to several rounds of questions received from the SSE. On July 12, 2022, the SSE approved the listing of Tongmei’s shares in an IPO on the STAR Market. On August 1, 2022, the China Securities Regulatory Commission (the “CSRC”) accepted for review Tongmei’s IPO application. The STAR Market IPO remains subject to review and approval by the CSRC and other authorities. The process of going public on the STAR Market includes several periods of review and, therefore, is a lengthy process. Subject to review and approval by the CSRC and other authorities, Tongmei hopes to accomplish this goal in the coming months. AXT has posted a brief summary of the plan and the process on its website at http://www.axt.com.

 ​

 

 

AXT, Inc. Fourth Quarter and Fiscal Year 2025 Results

February 19, 2026

Page 3 of 7

 ​

Conference Call

 ​

The company will host a conference call to discuss these results today at 1:30 p.m. PT. The conference call can be accessed at (800) 715-9871 (passcode 4378083). The call will also be simulcast at www.axt.com. Replays will be available at (800) 770-2030 (Playback ID: 4378083 followed by # key) until February 26, 2026. Financial and statistical information to be discussed in the call will be available on the company’s website immediately prior to commencement of the call. Additional investor information can be accessed at http://www.axt.com or by calling the company’s Investor Relations Department at (510) 438-4700.

 

About AXT, Inc.

 

AXT is a material science company that develops and manufactures high-performance compound and single element semiconductor wafer substrates comprising indium phosphide (InP), gallium arsenide (GaAs) and germanium (Ge). The company’s wafer substrates are used when a typical silicon wafer substrate cannot meet the performance requirements of a semiconductor or optoelectronic device. End markets include 5G infrastructure, data center connectivity (silicon photonics), passive optical networks, LED lighting, lasers, sensors, power amplifiers for wireless devices and satellite solar cells. AXT’s worldwide headquarters are in Fremont, California where the company maintains sales, administration and customer service functions. AXT has its Asia headquarters in Beijing, China and manufacturing facilities in three separate locations in China. In addition, as part of its supply chain strategy, the company has partial ownership in more than ten companies in China producing raw materials and consumables for its manufacturing process. For more information, see AXT’s website at http://www.axt.com.

 

Note Regarding Use of Non-GAAP Financial Measures

 

As discussed above, the company provides certain non-GAAP financial measures that exclude stock-based compensation in addition to, and not as a substitute for, or because it believes that such information is superior to, financial measures calculated in accordance with GAAP. The company believes that non-GAAP financial measures, when taken collectively, may be helpful to investors because they provide consistency and comparability with past financial performance and provide better comparability with our peer companies, many of which also use similar non-GAAP financial measures. Further, the company believes that these non-GAAP financial measures offer an important analytical tool to help investors understand the company’s core operating results and trends. In addition, management uses non-GAAP financial measures to compare the company’s performance relative to forecasts and strategic plans and to benchmark its performance externally against peer companies. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. In addition, other companies may calculate similarly-titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the company’s non-GAAP financial measures as tools for comparison. The company encourages investors to carefully consider its results under GAAP, as well as its supplemental non‐GAAP information and the reconciliation between these presentations, to more fully understand its business. A reconciliation of our GAAP consolidated financial statements to our non-GAAP consolidated financial statements is provided below.

 

 

 

AXT, Inc. Fourth Quarter and Fiscal Year 2025 Results

February 19, 2026

Page 4 of 7

 ​ ​

Forward-Looking Statements

 ​

The foregoing paragraphs contain forward-looking statements within the meaning of the Federal securities laws, including, for example, statements regarding the timing and completion of the proposed listing of shares of Tongmei on the STAR Market. Additional examples of forward-looking statements include statements regarding the market demand for our products, our product mix, our growth prospects and opportunities for continued business expansion, including trends, new applications and the ramping of Tier-1 customers, our market opportunity, our ability to lead our industry, our expectations with respect to our business prospects and financial results, including our gross margin performance, and our development of larger diameter substrates that we believe will enable the next generation of technology innovation across a number of end-markets. These forward-looking statements are based upon assumptions that are subject to uncertainties and factors relating to the company’s operations and business environment, which could cause actual results to differ materially from those expressed or implied in the forward-looking statements contained in the foregoing discussion. These uncertainties and factors include but are not limited to: the requests for redemptions by private equity funds in China of investments in Tongmei, the administrative challenges in satisfying the requirements of various government agencies in China in connection with the listing of shares of Tongmei on the STAR Market, continued open access to companies to list shares on the STAR Market, investor enthusiasm for new listings of shares on the STAR Market and geopolitical tensions between China and the United States. Additional uncertainties and factors include, but are not limited to: the timing and receipt of significant orders; the cancellation of orders and return of product; emerging applications using chips or devices fabricated on our substrates; end-user acceptance of products containing chips or devices fabricated on our substrates; our ability to bring new products to market; product announcements by our competitors; the ability to control costs and improve efficiency; the ability to utilize our manufacturing capacity; product yields and their impact on gross margins; the relocation of manufacturing lines and ramping of production; possible factory shutdowns as a result of air pollution in China or COVID-19; COVID-19 or other outbreaks of a contagious disease; tariffs and other trade war issues; the financial performance of our partially owned supply chain companies; policies and regulations in China; and other factors as set forth in the company’s Annual Report on Form 10-K, quarterly reports on Form 10-Q and other filings made with the Securities and Exchange Commission. Each of these factors is difficult to predict and many are beyond the company’s control. The company does not undertake any obligation to update any forward-looking statement, as a result of new information, future events or otherwise.

 ​

 ​

###

 ​

FINANCIAL TABLES TO FOLLOW

 ​

 

 

AXT, Inc. Fourth Quarter and Fiscal Year 2025 Results

February 19, 2026

Page 5 of 7

 ​

AXT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited, in thousands, except per share data)

 ​

   

Three Months Ended

   

Year Ended

 
   

December 31,

   

December 31,

 
   

2025

     

2024

   

2025

   

2024

 
                           

Revenue

  $ 23,041       $ 25,105     $ 88,326     $ 99,361  

Cost of revenue

    18,215         20,697       77,084       75,525  

Gross profit

    4,826         4,408       11,242       23,836  

Operating expenses:

                           

Selling, general and administrative

    6,266         6,440       24,169       24,096  

Research and development

    2,393         4,133       9,049       14,543  

Total operating expenses

    8,659         10,573       33,218       38,639  

Loss from operations

    (3,833 )       (6,165 )     (21,976 )     (14,803 )

Interest expense, net

    (391 )       (318 )     (1,257 )     (1,340 )

Equity in income of unconsolidated joint ventures

    173         944       765       3,439  

Other income (expense), net

    713         (5 )     924       2,047  

Loss before provision for income taxes

    (3,338 )       (5,544 )     (21,544 )     (10,657 )

Provision for income taxes

    501         113       1,658       1,134  

Net loss

    (3,839 )       (5,657 )     (23,202 )     (11,791 )

Less: Net loss attributable to noncontrolling interests and redeemable noncontrolling interests

    291         569       1,942       167  

Net loss attributable to AXT, Inc.

  $ (3,548 )     $ (5,088 )   $ (21,260 )   $ (11,624 )

Net loss attributable to AXT, Inc. per common share:

                           

Basic

  $ (0.08 )     $ (0.12 )   $ (0.49 )   $ (0.27 )

Diluted

  $ (0.08 )     $ (0.12 )   $ (0.49 )   $ (0.27 )

Weighted-average number of common shares outstanding:

                           

Basic

    44,719         43,381       43,933       43,154  

Diluted

    44,719         43,381       43,933       43,154  

 ​ 

 

 

AXT, Inc. Fourth Quarter and Fiscal Year 2025 Results

February 19, 2026

Page 6 of 7

 ​

AXT, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands)

 ​

     

December 31,

     

December 31,

 
      2025       2024  
                 

ASSETS

                 

Current assets:

                 

Cash and cash equivalents

    $ 120,266       $ 22,833  

Restricted cash

      8,100         10,978  

Accounts receivable, net

      26,849         25,640  

Inventories

      81,651         85,077  

Prepaid expenses and other current assets

      9,690         13,744  

Total current assets

      246,556         158,272  

Property, plant and equipment, net

      161,860         159,721  

Operating lease right-of-use assets

      1,982         2,479  

Other assets

      23,353         18,842  

Total assets

    $ 433,751       $ 339,314  

LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY

                 

Current liabilities:

                 

Accounts payable

    $ 12,947       $ 12,356  

Accrued liabilities

      14,798         14,556  

Short-term loans

      62,796         47,264  

Total current liabilities

      90,541         74,176  

Noncurrent operating lease liabilities

      1,441         1,977  

Other long-term liabilities

      7,138         8,253  

Total liabilities

      99,120         84,406  
                 

Redeemable noncontrolling interests

      38,056         38,577  
                 

Stockholders’ equity:

                 

Preferred stock

      3,532         3,532  

Common stock

      55         45  

Additional paid-in capital

      339,922         241,514  

Accumulated deficit

      (64,924 )       (43,664 )

Accumulated other comprehensive loss

      (5,295 )       (8,657 )

Total AXT, Inc. stockholders’ equity

      273,290         192,770  

Noncontrolling interests

      23,285         23,561  

Total stockholders’ equity

      296,575         216,331  

Total liabilities, redeemable noncontrolling interests and stockholders’ equity

    $ 433,751       $ 339,314  

 ​ ​

 

 

AXT, Inc. Fourth Quarter and Fiscal Year 2025 Results

February 19, 2026

Page 7 of 7

 ​

AXT, INC.

Reconciliation of Statements of Operations Under GAAP and Non-GAAP

(Unaudited, in thousands)

 ​

   

Three Months Ended

   

Year Ended

 
   

December 31,

   

December 31,

 
   

2025

   

2024

   

2025

   

2024

 

GAAP gross profit

  $ 4,826     $ 4,408     $ 11,242     $ 23,836  

Stock-based compensation expense

    130       76       289       322  

Non-GAAP gross profit

  $ 4,956     $ 4,484     $ 11,531     $ 24,158  
                         

GAAP operating expenses

  $ 8,659     $ 10,573     $ 33,218     $ 38,639  

Stock-based compensation expense

    1,145       677       3,003       2,775  

Non-GAAP operating expenses

  $ 7,514     $ 9,896     $ 30,215     $ 35,864  
                         

GAAP loss from operations

  $ (3,833 )   $ (6,165 )   $ (21,976 )   $ (14,803 )

Stock-based compensation expense

    1,275       753       3,292       3,097  

Non-GAAP loss from operations

  $ (2,558 )   $ (5,412 )   $ (18,684 )   $ (11,706 )
                         

GAAP net loss

  $ (3,548 )   $ (5,088 )   $ (21,260 )   $ (11,624 )

Stock-based compensation expense

    1,275       753       3,292       3,097  

Non-GAAP net loss

  $ (2,273 )   $ (4,335 )   $ (17,968 )   $ (8,527 )
                         

GAAP net loss per diluted share

  $ (0.08 )   $ (0.12 )   $ (0.49 )   $ (0.27 )

Stock-based compensation expense per diluted share

  $ 0.03     $ 0.02     $ 0.07     $ 0.07  

Non-GAAP net loss per diluted share

  $ (0.05 )   $ (0.10 )   $ (0.41 )   $ (0.20 )
                         

Shares used to compute diluted net income per share

    44,719       43,381       43,933       43,154  

 ​

 

FAQ

How did AXT (AXTI) perform financially in full-year 2025?

AXT reported 2025 revenue of $88.3 million, down from $99.4 million in 2024. GAAP net loss attributable to AXT widened to $21.3 million, while non-GAAP net loss was $18.0 million, reflecting weaker demand and ongoing investment.

What were AXT (AXTI) fourth quarter 2025 results?

In Q4 2025, AXT generated $23.0 million in revenue versus $25.1 million a year earlier. GAAP net loss attributable to AXT was $3.5 million, or $0.08 per diluted share, with non-GAAP net loss of $2.3 million, or $0.05 per share.

What is AXT (AXTI) management’s outlook for 2026 and AI demand?

Management expects sequential revenue growth in Q1 2026, driven primarily by indium phosphide demand for AI infrastructure. AXT plans to double indium phosphide manufacturing capacity in 2026 and is broadening its customer base to include more Tier-1 companies.

How strong is AXT (AXTI)’s balance sheet at year-end 2025?

At December 31, 2025, AXT reported $120.3 million in cash and cash equivalents, up from $22.8 million a year earlier. Total assets reached $433.8 million, and AXT, Inc. stockholders’ equity increased to $273.3 million.

What non-GAAP financial measures did AXT (AXTI) report for 2025?

AXT reported 2025 non-GAAP gross profit of $11.5 million and non-GAAP operating expenses of $30.2 million. Non-GAAP net loss was $18.0 million, or $0.41 per diluted share, excluding $3.3 million of stock-based compensation.

What is the status of AXT’s Tongmei STAR Market IPO plan?

Tongmei’s proposed IPO on the STAR Market received listing approval from the Shanghai Stock Exchange and review acceptance from the CSRC. The listing remains subject to review and approval by the CSRC and other authorities, and the process is described as lengthy.

Did AXT (AXTI) discuss any risks or uncertainties in this update?

AXT highlighted risks including Chinese private equity redemption requests in Tongmei, administrative and regulatory challenges for the STAR Market listing, trade tensions, tariffs, order timing, COVID-19 or other outbreaks, and policy changes in China, all of which could affect future results.

Filing Exhibits & Attachments

5 documents
Axt Inc

NASDAQ:AXTI

AXTI Rankings

AXTI Latest News

AXTI Latest SEC Filings

AXTI Stock Data

1.32B
51.85M
Semiconductor Equipment & Materials
Semiconductors & Related Devices
Link
United States
FREMONT